Pure Bioscience shareholders approve increase in authorized shares to 250M

PURE BIOSCIENCE, INC.

Approved amendment increasing authorized common shares from 200M to 250M, with 63.87% of outstanding shares voting for.
Elected 7 directors, each receiving over 96% of votes cast.
Ratified Weinberg & Company as auditor for FY 2026 (99.81% approval).
Advisory vote on executive compensation passed with 96.68% support.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.